Stock-Based Compensation (Details) - Schedule of Stock Option Activities - Stock option [Member] - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended	12 Months Ended
		Mar. 31, 2024	Dec. 31, 2023
Stock-Based Compensation [Line Items]
Number of Options, Balance at ending (in Shares)		4,001,878	2,900,205
Weighted Average Exercise Price, Balance at ending		$ 7.41	$ 9.5
Weighted Average Remaining Contractual Term (years), Balance at ending		7 years 5 months 12 days	8 years 10 days
Aggregate Intrinsic Value, Balance at ending (in Dollars)	[1]	$ 3,675	$ 20
Number of Options, Granted (in Shares)		1,102,300
Weighted Average Exercise Price, Granted		$ 1.91
Weighted Average Remaining Contractual Term (years), Granted
Aggregate Intrinsic Value, Granted
Number of Options, Exercised (in Shares)
Weighted Average Exercise Price, Exercised
Weighted Average Remaining Contractual Term (years), Exercised
Aggregate Intrinsic Value, Exercised (in Dollars)
Number of Options, Forfeited (in Shares)
Weighted Average Exercise Price, Forfeited
Weighted Average Remaining Contractual Term (years), Forfeited
Aggregate Intrinsic Value, Forfeited
Number of Options, Expired (in Shares)		(627)
Weighted Average Exercise Price, Expired		$ 3.2
Weighted Average Remaining Contractual Term (years), Expired
Aggregate Intrinsic Value, Expired (in Dollars)
Number of Options, Vested or expected to vest (in Shares)		4,001,878
Weighted Average Exercise Price, Vested or expected to vest		$ 7.41
Weighted Average Remaining Contractual Term (years), Vested or expected to vest		7 years 5 months 12 days
Aggregate Intrinsic Value, Vested or expected to vest (in Dollars)	[1]	$ 3,675
Number of Options, Exercisable (in Shares)		1,648,715
Weighted Average Exercise Price, Exercisable		$ 12.9
Weighted Average Remaining Contractual Term (years), Exercisable		6 years 8 months 15 days
Aggregate Intrinsic Value, Exercisable (in Dollars)	[1]	$ 429

[1] Aggregate intrinsic value represents the difference between the exercise price of the option and the closing market price of our common stock on December 31, 2023 and March 31, 2024, respectively. The intrinsic value of options exercised during the period ended March 31, 2024 was $0 and no options were exercised.